[1] Anderson G L，Limacher M，Assaf A R,et al.Effects of conjugated equine estrogen in postmenopausal women with hysterectomy：the women’s health initiative randomized controlled trial[J].Journal of the American Medical Association，2004，291:1701-1712. [2]Strothmann A，Schneider H P G.Hormone therapy：the European women’s perspective[J].Climacteric，2003,6：337-346.
[3]Lukaczer D，Liska D J，Lerman R H,et al.Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women[J].Nutrition，2006,22:104-113.
[4]Uesugi T，Fukui Y，Yamori Y.Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women：a four-week study[J].Journal of the American College of Cardiology，2002,21：97-102.
[5]Jayagopal V，Albertazzi P，Kilpatrick E S，et al.Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes[J].Diabetes Care，2002,25:1709-1714.
[6] Wu A H，Stanczyk F Z，Martinez C，et al.A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women[J].American Journal of Clinical Nutrition，2005,81:1133-1141.
[7]Reimann M，Dierkes J，Carlsohn A，et al.Consumption of soy isoflavones does not affect plasma total homocysteine or asymmetric dimethylarginine concentrations in healthy postmenopausal women[J].The Journal of Nutrition，2006,136:100-105.
[8] Verhoeven M O，Hemelaar M，van der Mooren M J,et al.Oral more than transdermal，oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women：a randomized，placebo-controlled study[J].Journal of Internal Medicine，2006,259:199-208.
[9]Engelman H M，Alekel D L，Hanson L N，et al.Effects of soy isoflavones and phytate on homocysteine，C-reactive protein，and iron status in postmenopausal women[J].American Journal of Clinical Nutrition，2006,84:774-780.
[10]Roudsari A H，Tahbaz F，Hossein-Nezhad A，et al.Assessment of soy phytoestrogens’ effects on bone turnover indicators in menopausal women with osteopenia in Iran：a before and after clinical trial[J].Nutrition Journal，2005,4：30-39.
[11]Ikeda Y，Iki M，Morita A，et al.Intake of fermented soybeans，Natto，is associated with reduced bone loss in postmenopausal women：Japanese population-based osteoporosis（JPOS) study[J].The Journal of Nutrition，2006,2:1323-1328.
[12]Arjmandi B H，Lucas E A，Khalil D A，et al.One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women[J].Nutrition Journal，2005,4：8-15.
[13]Ye Y B，Tang X Y，Verbruggen M A，et al.Soy isoflavones attenuate bone loss in early postmenopausal Chinese women A single-blind randomized，placebo-controlled trial[J].European Journal of Nutrition，2006,45：327-334.
[14]Moeller L E，Peterson C T，Hanson K B，et al.Isoflavone-rich soy protein prevents loss of hip lean mass but dos not prevent the shift in regional fat distribution in perimenopausal women[J].Menopause，2003,4：322-331.
[15]Weickert M O，Reimann M，Otto B，et al.Soy isoflavones increase preprandial peptide YY（PYY)，but have no effect on ghrelin and body weight in healthy postmenopausal women[J].Journal of Negative Results in BioMedicine，2006,5：11.
[16]Kok L，Kreijkamp-Kaspers S，Grobbee D E，et al.Soy isoflavones，body composition，and physical performance[J].Maturitas，2005,52:102-110.[17] Wu A H，Wan P，Hankin J，et al.Adolescent and adult soy intake and risk of breast cancer in Asian-Americans [J].Carcinogenesis，2002,23：1491-1496.
[18]Yamamoto S，Sobue T，Kobayashi M，et al.Soy，isoflavones，and breast cancer risk in Japan[J].The Journal of the National Cancer Institute，2003,95：906-913.
[19]Dai Q，Shu X O，Jin F，et al.Population-based case-control study of soyfood intake and breast cancer risk in Shanghai[J].British Journal of Cancer，2001,85：372-378.
[20]MacGregor C A，Canney P A，Patterson G，et al.A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer[J].European Journal of Cancer，2005,41：708-714.